Wockhardt’s Chikalthana unit gets GMP certificate from UK MHRA

21 Dec 2016 Evaluate

UK health regulator -- UK Medicines and Healthcare Products Regulatory Agency (UK MHRA) has confirmed that Wockhardt’s manufacturing facility at Chikalthana in Maharashtra complies with good manufacturing practices (GMP).

Further, UK MHRA has considered the said manufacturing unit suitable for risk based inspection with reduced inspection frequency of two years from the existing inspection frequency of 1 year.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1172.35 -14.60 (-1.23%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.